Compare Stocks

3 / 10
Try these comparisons:

Stock Comparison

EYE vs NVST vs HSIC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
EYE
National Vision Holdings, Inc.

Specialty Retail

Consumer CyclicalNASDAQ • US
Market Cap$1.82B
5Y Perf.-14.3%
NVST
Envista Holdings Corp

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$3.95B
5Y Perf.+14.7%
HSIC
Henry Schein, Inc.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$8.13B
5Y Perf.+16.6%

EYE vs NVST vs HSIC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
EYE logoEYE
NVST logoNVST
HSIC logoHSIC
IndustrySpecialty RetailMedical - Equipment & ServicesMedical - Distribution
Market Cap$1.82B$3.95B$8.13B
Revenue (TTM)$1.99B$2.81B$13.18B
Net Income (TTM)$30M$68M$398M
Gross Margin56.5%55.1%29.1%
Operating Margin3.0%9.0%5.8%
Forward P/E32.8x17.0x13.2x
Total Debt$695M$1.71B$3.69B
Cash & Equiv.$39M$1.21B$156M

EYE vs NVST vs HSICLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

EYE
NVST
HSIC
StockMay 20May 26Return
National Vision Hol… (EYE)10085.7-14.3%
Envista Holdings Co… (NVST)100114.7+14.7%
Henry Schein, Inc. (HSIC)100116.6+16.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: EYE vs NVST vs HSIC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HSIC leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. National Vision Holdings, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
EYE
National Vision Holdings, Inc.
The Income Pick

EYE is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 2 yrs, beta 1.59
  • Rev growth 9.0%, EPS growth 202.8%, 3Y rev CAGR 6.5%
  • 9.0% revenue growth vs HSIC's 4.0%
Best for: income & stability and growth exposure
NVST
Envista Holdings Corp
The Quality Angle

NVST plays a supporting role in this comparison — it may shine differently against other peers.

Best for: healthcare exposure
HSIC
Henry Schein, Inc.
The Long-Run Compounder

HSIC carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • 5.8% 10Y total return vs NVST's -13.3%
  • Lower volatility, beta 0.72, Low D/E 76.9%, current ratio 1.38x
  • PEG 4.20 vs NVST's 11.37
Best for: long-term compounding and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthEYE logoEYE9.0% revenue growth vs HSIC's 4.0%
ValueHSIC logoHSICLower P/E (13.2x vs 17.0x), PEG 4.20 vs 11.37
Quality / MarginsHSIC logoHSIC3.0% margin vs EYE's 1.5%
Stability / SafetyHSIC logoHSICBeta 0.72 vs NVST's 1.63
DividendsTieNone of these 3 stocks pay a meaningful dividend
Momentum (1Y)EYE logoEYE+37.6% vs HSIC's +2.8%
Efficiency (ROA)HSIC logoHSIC3.6% ROA vs NVST's 1.2%, ROIC 7.1% vs 4.8%

EYE vs NVST vs HSIC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

EYENational Vision Holdings, Inc.
FY 2025
Product Sales
44.7%$1.6B
Eyeglasses And Sunglasses
35.3%$1.3B
Services And Plans
10.7%$383M
Contact Lenses
9.0%$324M
Accessories And Other
0.3%$11M
NVSTEnvista Holdings Corp
FY 2024
Specialty Products and Technologies
64.4%$1.6B
Equipment and Consumables
35.6%$894M
HSICHenry Schein, Inc.
FY 2018
Healthcare Distribution
96.1%$12.7B
Technology
3.9%$509M

EYE vs NVST vs HSIC — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLEYELAGGINGHSIC

Income & Cash Flow (Last 12 Months)

NVST leads this category, winning 3 of 6 comparable metrics.

HSIC is the larger business by revenue, generating $13.2B annually — 6.6x EYE's $2.0B. Profitability is closely matched — net margins range from 3.0% (HSIC) to 1.5% (EYE). On growth, EYE holds the edge at +15.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricEYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
RevenueTrailing 12 months$2.0B$2.8B$13.2B
EBITDAEarnings before interest/tax$153M$342M$1.1B
Net IncomeAfter-tax profit$30M$68M$398M
Free Cash FlowCash after capex$73M$220M$561M
Gross MarginGross profit ÷ Revenue+56.5%+55.1%+29.1%
Operating MarginEBIT ÷ Revenue+3.0%+9.0%+5.8%
Net MarginNet income ÷ Revenue+1.5%+2.4%+3.0%
FCF MarginFCF ÷ Revenue+3.7%+7.8%+4.3%
Rev. Growth (YoY)Latest quarter vs prior year+15.1%+14.4%+7.7%
EPS Growth (YoY)Latest quarter vs prior year+111.3%+130.0%+14.9%
NVST leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

HSIC leads this category, winning 6 of 7 comparable metrics.

At 21.7x trailing earnings, HSIC trades at a 75% valuation discount to NVST's 86.6x P/E. Adjusting for growth (PEG ratio), HSIC offers better value at 6.87x vs NVST's 57.98x — a lower PEG means you pay less per unit of expected earnings growth.

MetricEYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
Market CapShares × price$1.8B$4.0B$8.1B
Enterprise ValueMkt cap + debt − cash$2.5B$4.4B$11.7B
Trailing P/EPrice ÷ TTM EPS62.05x86.57x21.66x
Forward P/EPrice ÷ next-FY EPS est.32.78x16.97x13.25x
PEG RatioP/E ÷ EPS growth rate57.98x6.87x
EV / EBITDAEnterprise value multiple16.27x13.01x10.90x
Price / SalesMarket cap ÷ Revenue0.92x1.45x0.62x
Price / BookPrice ÷ Book value/share2.13x1.32x1.80x
Price / FCFMarket cap ÷ FCF24.82x17.15x14.18x
HSIC leads this category, winning 6 of 7 comparable metrics.

Profitability & Efficiency

Evenly matched — NVST and HSIC each lead in 4 of 9 comparable metrics.

HSIC delivers a 8.2% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $2 for NVST. NVST carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to EYE's 0.80x. On the Piotroski fundamental quality scale (0–9), EYE scores 7/9 vs HSIC's 4/9, reflecting strong financial health.

MetricEYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
ROE (TTM)Return on equity+3.5%+2.2%+8.2%
ROA (TTM)Return on assets+1.5%+1.2%+3.6%
ROICReturn on invested capital+3.0%+4.8%+7.1%
ROCEReturn on capital employed+3.8%+4.9%+9.8%
Piotroski ScoreFundamental quality 0–9774
Debt / EquityFinancial leverage0.80x0.55x0.77x
Net DebtTotal debt minus cash$656M$496M$3.5B
Cash & Equiv.Liquid assets$39M$1.2B$156M
Total DebtShort + long-term debt$695M$1.7B$3.7B
Interest CoverageEBIT ÷ Interest expense3.54x12.76x4.59x
Evenly matched — NVST and HSIC each lead in 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

EYE leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in HSIC five years ago would be worth $8,536 today (with dividends reinvested), compared to $4,473 for EYE. Over the past 12 months, EYE leads with a +37.6% total return vs HSIC's +2.8%. The 3-year compound annual growth rate (CAGR) favors EYE at 0.9% vs NVST's -11.4% — a key indicator of consistent wealth creation.

MetricEYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
YTD ReturnYear-to-date-11.5%+11.8%-7.8%
1-Year ReturnPast 12 months+37.6%+36.4%+2.8%
3-Year ReturnCumulative with dividends+2.8%-30.4%-11.3%
5-Year ReturnCumulative with dividends-55.3%-46.5%-14.6%
10-Year ReturnCumulative with dividends-17.5%-13.3%+5.8%
CAGR (3Y)Annualised 3-year return+0.9%-11.4%-3.9%
EYE leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — NVST and HSIC each lead in 1 of 2 comparable metrics.

HSIC is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than NVST's 1.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVST currently trades 79.7% from its 52-week high vs EYE's 76.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricEYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
Beta (5Y)Sensitivity to S&P 5001.59x1.63x0.72x
52-Week HighHighest price in past year$30.02$30.42$89.29
52-Week LowLowest price in past year$15.74$16.41$61.95
% of 52W HighCurrent price vs 52-week peak+76.5%+79.7%+79.3%
RSI (14)Momentum oscillator 0–10041.836.434.3
Avg Volume (50D)Average daily shares traded1.4M2.5M1.2M
Evenly matched — NVST and HSIC each lead in 1 of 2 comparable metrics.

Analyst Outlook

EYE leads this category, winning 1 of 1 comparable metric.

Analyst consensus: EYE as "Buy", NVST as "Hold", HSIC as "Hold". Consensus price targets imply 53.3% upside for EYE (target: $35) vs 13.2% for NVST (target: $27).

MetricEYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
Analyst RatingConsensus buy/hold/sellBuyHoldHold
Price TargetConsensus 12-month target$35.20$27.44$85.43
# AnalystsCovering analysts141932
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises21
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+0.2%+4.2%+10.5%
EYE leads this category, winning 1 of 1 comparable metric.
Key Takeaway

EYE leads in 2 of 6 categories (Total Returns, Analyst Outlook). NVST leads in 1 (Income & Cash Flow). 2 tied.

Best OverallNational Vision Holdings, I… (EYE)Leads 2 of 6 categories
Loading custom metrics...

EYE vs NVST vs HSIC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is EYE or NVST or HSIC a better buy right now?

For growth investors, National Vision Holdings, Inc.

(EYE) is the stronger pick with 9. 0% revenue growth year-over-year, versus 4. 0% for Henry Schein, Inc. (HSIC). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 7x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate National Vision Holdings, Inc. (EYE) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — EYE or NVST or HSIC?

On trailing P/E, Henry Schein, Inc.

(HSIC) is the cheapest at 21. 7x versus Envista Holdings Corp at 86. 6x. On forward P/E, Henry Schein, Inc. is actually cheaper at 13. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Henry Schein, Inc. wins at 4. 20x versus Envista Holdings Corp's 11. 37x.

03

Which is the better long-term investment — EYE or NVST or HSIC?

Over the past 5 years, Henry Schein, Inc.

(HSIC) delivered a total return of -14. 6%, compared to -55. 3% for National Vision Holdings, Inc. (EYE). Over 10 years, the gap is even starker: HSIC returned +5. 8% versus EYE's -17. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — EYE or NVST or HSIC?

By beta (market sensitivity over 5 years), Henry Schein, Inc.

(HSIC) is the lower-risk stock at 0. 72β versus Envista Holdings Corp's 1. 63β — meaning NVST is approximately 126% more volatile than HSIC relative to the S&P 500. On balance sheet safety, Envista Holdings Corp (NVST) carries a lower debt/equity ratio of 55% versus 80% for National Vision Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — EYE or NVST or HSIC?

By revenue growth (latest reported year), National Vision Holdings, Inc.

(EYE) is pulling ahead at 9. 0% versus 4. 0% for Henry Schein, Inc. (HSIC). On earnings-per-share growth, the picture is similar: National Vision Holdings, Inc. grew EPS 202. 8% year-over-year, compared to 7. 2% for Henry Schein, Inc.. Over a 3-year CAGR, EYE leads at 6. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — EYE or NVST or HSIC?

Henry Schein, Inc.

(HSIC) is the more profitable company, earning 3. 0% net margin versus 1. 5% for National Vision Holdings, Inc. — meaning it keeps 3. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVST leads at 8. 3% versus 3. 1% for EYE. At the gross margin level — before operating expenses — NVST leads at 55. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is EYE or NVST or HSIC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Henry Schein, Inc. (HSIC) is the more undervalued stock at a PEG of 4. 20x versus Envista Holdings Corp's 11. 37x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Henry Schein, Inc. (HSIC) trades at 13. 2x forward P/E versus 32. 8x for National Vision Holdings, Inc. — 19. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EYE: 53. 3% to $35. 20.

08

Which pays a better dividend — EYE or NVST or HSIC?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is EYE or NVST or HSIC better for a retirement portfolio?

For long-horizon retirement investors, Henry Schein, Inc.

(HSIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72)). Envista Holdings Corp (NVST) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HSIC: +5. 8%, NVST: -13. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between EYE and NVST and HSIC?

These companies operate in different sectors (EYE (Consumer Cyclical) and NVST (Healthcare) and HSIC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

EYE

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 33%
Run This Screen
Stocks Like

NVST

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 33%
Run This Screen
Stocks Like

HSIC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 17%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform EYE and NVST and HSIC on the metrics below

Revenue Growth>
%
(EYE: 15.1% · NVST: 14.4%)
P/E Ratio<
x
(EYE: 62.1x · NVST: 86.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.